1 / 12

Genetics and Biomarkers in Congenital Heart Disease

Genetics and Biomarkers in Congenital Heart Disease. SSA Conference, November 9, 2010. Allen D. Everett, MD Associate Professor, Pediatric Cardiology Helen B. Taussig Children’s Congenital Heart Center. Translating Congenital Heart Disease for the Non-Cardiologist.

kellsie
Download Presentation

Genetics and Biomarkers in Congenital Heart Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Genetics and Biomarkers in Congenital Heart Disease SSA Conference, November 9, 2010 Allen D. Everett, MD Associate Professor, Pediatric Cardiology Helen B. Taussig Children’s Congenital Heart Center

  2. Translating Congenital Heart Disease for the Non-Cardiologist This is a difficult task but I hope to better than this translation:

  3. Genetics of Congenital Heart Disease

  4. Genetics of Congenital Heart Disease Syndromic-Congenital heart disease associated with other defects such as brain, liver, etc. Uncommon, and tend to be single gene defects Noonan’s (CHD, hematologic, neurologic) PTPN11 Alagille’s (CHD, liver disease) JAG1 Holt-Oram (CHD, skeletal defects) TBX5

  5. Genetics of Congenital Heart Disease • Non-syndromic-Congenital heart disease alone. Sporadic and common. • Incidence of gene mutations is low. In Hypoplastic left heart syndrome, the incidence of mutations in NKX2.5, NOTCH1, HAND1 and GJA1 is 2%. • Therefore occurrence is related to multifactoral inheritance of a multitude of susceptibility genes (unknown) with low penetrance mutations (being discovered) superimposed on unfavorable environmental conditions (unknown).

  6. Genetics of Congenital Heart Disease • Chromosomal deletions • 22q11: Tetralogy of Fallot, Interrupted aortic arch and Tricuspid atresia. • Other less common are 9q34, 1q21.1, 16p11.2 and 17p11.2. • The use of genomic array technologies for routine genetic screening is identifying an increasing number of chromosome microdeletions in children with CHD.

  7. Genetics of Congenital Heart Disease MW Wessels and PJ Willems. Clin. Genetics, 2010 78:103

  8. Biomarkers in Congenital Heart Disease • Biomarker (HUPO): Used to indicate or measure a biological process (for instance, levels of a specific protein in blood or spinal fluid, genetic mutations, or brain abnormalities observed in a PET scan or other imaging test). Detecting biomarkers specific to a disease can aid in the identification, diagnosis, and treatment of affected individuals and people who may be at risk but do not yet exhibit symptoms.

  9. Biomarkers in Congenital Heart Disease • Classic example is measurement of specific heart muscle proteins (troponin I) released into the circulation after a myocardial infarction. • The heart also secretes hormones into the circulation when the workload of the heart is excessive. • Brain naturetic peptide (BNP)

  10. Biomarkers in Congenital Heart Disease • BNP • Shown to be a significant diagnostic measure of heart failure in adults • In patients with pulmonary hypertension, a significant predictor of sudden death • In children with CHD a potential indicator of poor heart function and recovery after heart surgery • In the non-surgical setting the levels are so high in children with CHD that they have little value. • May be useful in detecting transplant rejection.

  11. Biomarkers in Congenital Heart Disease • Brain Injury Biomarkers • 36-60% of neonates having surgery for CHD will have evidence of new brain injury on MRI • Peri-operative brain injury is the most significant morbidity of CHD repair. The average Psychomotor Development Index score after CHD repair is 85, with normal 100. • Identification of circulating brain specific proteins released with injury (similar to what happens with a myocardial infarction) will help improve and standardize perioperative care to reduce brain injury.

  12. Translating Congenital Heart Disease for the Non-Cardiologist I hope my translation came out better than this:

More Related